GFS
EW icon

GYL Financial Synergies’s Edwards Lifesciences EW Stock Holding History

GYL Financial Synergies’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,011
Closed -$1.89M – 333
2023
Q2 		$1.89M Buy
+20,011
New +$1.74M 0.17% 117

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

GYL Financial Synergies's EW Position: Q3 2023 in Review

GYL Financial Synergies sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 20,011 shares — an estimated $1.89M sold.

GYL Financial Synergies first reported a position in EW in Q2 2023 and held it in 1 quarter. The position peaked at $1.89M in Q2 2023. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • GYL Financial Synergies reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
  • GYL Financial Synergies sold 20,011 Edwards Lifesciences shares in Q3 2023, an estimated $1.89M.
  • GYL Financial Synergies first reported a position in Edwards Lifesciences in Q2 2023 and held it in 1 quarter.
  • GYL Financial Synergies's Edwards Lifesciences position peaked at $1.89M in Q2 2023.
  • 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on GYL Financial Synergies's 13F filing for Q3 2023, filed 6 Nov 2023.